The DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index.
Pathogenic mechanisms of pulmonary arterial hypertension
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Clinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
Giaid, A., Yanagisawa, M., Langleben, D., Michel, R. P., Levy, R., Shennib, H., Kimura, S., Masaki, T., Duguid, W. P., & Stewart, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282402 · Cited by 1,842
Controlling TGF-beta signaling.
Massagué, J., & Chen, Y. (2000) · PubMed · Cited by 1,780
Cellular and molecular pathobiology of pulmonary arterial hypertension
Humbert, M., Morrell, N. W., Archer, S. L., Stenmark, K. R., MacLean, M. R., Lang, I. M., Christman, B. W., Weir, E. K., Eickelberg, O., Voelkel, N. F., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.029 · Cited by 1,576
Massagué, J., & Chen, Y.-G. (2000) · Genes & Development · doi:10.1101/gad.14.6.627 · Cited by 1,575
Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice
Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., et al. (2001) · Science · doi:10.1126/science.1062688 · Cited by 1,552
Lane, K. B., Machado, R. D., Pauciulo, M. W., Thomson, J. R., Phillips, J. A., Loyd, J. E., Nichols, W. C., & Trembath, R. C. (2000) · Nature Genetics · doi:10.1038/79226 · Cited by 1,495
Pulmonary Arterial Hypertension
Farber, H. W., & Loscalzo, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035488 · Cited by 1,463
Self-citationGiaid, A., & Saleh, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330403 · Cited by 1,369
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Deng, Z., Morse, J. H., Slager, S. L., Cuervo, N., Moore, K. J., Venetos, G., Kalachikov, S., Cayanis, E., Fischer, S. G., Barst, R. J., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/303059 · Cited by 1,206
Christman, B. W., McPherson, C. D., Newman, J. H., King, G. A., Bernard, G. R., Groves, B. M., & Loyd, J. E. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270202 · Cited by 1,187
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350901 · Cited by 1,162
Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
Chambers, C. D., Hernandez-Diaz, S., Van Marter, L. J., Werler, M. M., Louik, C., Jones, K. L., & Mitchell, A. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052744 · Cited by 880
TARASEVICIENE‐STEWART, L., KASAHARA, Y., ALGER, L., HIRTH, P., MAHON, G. M., WALTENBERGER, J., VOELKEL, N. F., & TUDER, R. M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0343com · Cited by 817
TUDER, R. M., COOL, C. D., GERACI, M. W., WANG, J., ABMAN, S. H., WRIGHT, L., BADESCH, D., & VOELKEL, N. F. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.6.9804054 · Cited by 806
Acylation Targets Endothelial Nitric-oxide Synthase to Plasmalemmal Caveolae
Shaul, P. W., Smart, E. J., Robinson, L. J., German, Z., Yuhanna, I. S., Ying, Y., Anderson, R. G. W., & Michel, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6518 · Cited by 800
Thomson, J. R., Machado, R. D., Pauciulo, M. W., Morgan, N. V., Humbert, M., Elliott, G. C., Ward, K., Yacoub, M., Mikhail, G., Rogers, P., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.10.741 · Cited by 732
Trembath, R. C., Thomson, J. R., Machado, R. D., Morgan, N. V., Atkinson, C., Winship, I., Simonneau, G., Galie, N., Loyd, J. E., Humbert, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450503 · Cited by 725
Atkinson, C., Stewart, S., Upton, P. D., Machado, R., Thomson, J. R., Trembath, R. C., & Morrell, N. W. (2002) · Circulation · doi:10.1161/01.cir.0000012754.72951.3d · Cited by 697
Pulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 664
Loscalzo, J., Kohane, I., & Barabasi, A. (2007) · Molecular Systems Biology · doi:10.1038/msb4100163 · Cited by 603
Self-citationAtrial Septal Defects in the Adult: Recent Progress and Overview
Webb, G., & Gatzoulis, M. A. (2006) · Circulation · doi:10.1161/circulationaha.105.592055 · Cited by 590
Tuder, R. M., Flook, B. E., & Voelkel, N. F. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117858 · Cited by 588
Eddahibi, S., Humbert, M. J. C., Fadel, É., Raffestin, B., Darmon, M. C., Capron, F., Simonneau, G., Dartevelle, P., Hamon, M., & Adnot, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12805 · Cited by 579
Increased plasma serotonin in primary pulmonary hypertension
Hervé, P., Launay, J.-M., Scrobohaci, M.-L., Brenot, F., Simonneau, G., Petitpretz, P., Poubeau, P., Cerrina, J., Duroux, P., & Drouet, L. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80156-9 · Cited by 560
BMPR2 Haploinsufficiency as the Inherited Molecular Mechanism for Primary Pulmonary Hypertension
Machado, R. D., Pauciulo, M. W., Thomson, J. R., Lane, K. B., Morgan, N. V., Wheeler, L., Phillips III, J. A., Newman, J., Williams, D., Galiè, N., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/316947 · Cited by 535
Tuder, R. M., Chacon, M., Alger, L., Wang, J., Taraseviciene‐Stewart, L., Kasahara, Y., Cool, C. D., Bishop, A. E., Geraci, M., Semenza, G. L., et al. (2001) · The Journal of Pathology · doi:10.1002/path.953 · Cited by 500
Signaling and Functions of Angiopoietin-1 in Vascular Protection
Brindle, N. P. J., Saharinen, P., & Alitalo, K. (2006) · Circulation Research · doi:10.1161/01.res.0000218275.54089.12 · Cited by 487
Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine
Shimokawa, H., & Takeshita, A. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000176193.83629.c8 · Cited by 480
Rho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide Synthase
Takemoto, M., Sun, J., Hiroki, J., Shimokawa, H., & Liao, J. K. (2002) · Circulation · doi:10.1161/01.cir.0000020682.73694.ab · Cited by 475
Hypoxic pulmonary vasoconstriction
Moudgil, R., Michelakis, E. D., & Archer, S. L. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00733.2004 · Cited by 454
Morrell, N. W., Yang, X., Upton, P. D., Jourdan, K. B., Morgan, N., Sheares, K. K., & Trembath, R. C. (2001) · Circulation · doi:10.1161/hc3201.094152 · Cited by 453
Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice
Zhao, Y.-Y., Liu, Y., Stan, R.-V., Fan, L., Gu, Y., Dalton, N., Chu, P.-H., Peterson, K., Ross, J., & Chien, K. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172360799 · Cited by 448
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
Launay, J.-M., Hervé, P., Peoc'h, K., Tournois, C., Callebert, J., Nebigil, C. G., Etienne, N., Drouet, L., Humbert, M., Simonneau, G., et al. (2002) · Nature Medicine · doi:10.1038/nm764 · Cited by 433
Yu, Y., Fantozzi, I., Remillard, C. V., Landsberg, J. W., Kunichika, N., Platoshyn, O., Tigno, D. D., Thistlethwaite, P. A., Rubin, L. J., & Yuan, J. X.-J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405908101 · Cited by 430
Lee, S. D., Shroyer, K. R., Markham, N. E., Cool, C. D., Voelkel, N. F., & Tuder, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1910 · Cited by 428
BMP Type II Receptor Is Required for Gastrulation and Early Development of Mouse Embryos
Beppu, H., Kawabata, M., Hamamoto, T., Chytil, A., Minowa, O., Noda, T., & Miyazono, K. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9670 · Cited by 421
Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice
Yet, S.-F., Perrella, M. A., Layne, M. D., Hsieh, C.-M., Maemura, K., Kobzik, L., Wiesel, P., Christou, H., Kourembanas, S., & Lee, M.-E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6163 · Cited by 410
Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension
Machado, R. D., Aldred, M. A., James, V., Harrison, R. E., Patel, B., Schwalbe, E. C., Gruenig, E., Janssen, B., Koehler, R., Seeger, W., et al. (2006) · Human Mutation · doi:10.1002/humu.20285 · Cited by 402
Abe, K., Shimokawa, H., Morikawa, K., Uwatoku, T., Oi, K., Matsumoto, Y., Hattori, T., Nakashima, Y., Kaibuchi, K., Sueishi, K., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000111804.34509.94 · Cited by 402
Signaling Molecules in Nonfamilial Pulmonary Hypertension
Du, L., Sullivan, C. C., Chu, D., Cho, A. J., Kido, M., Wolf, P. L., Yuan, J. X.-J., Deutsch, R., Jamieson, S. W., & Thistlethwaite, P. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021650 · Cited by 400
Inhaled Nitric Oxide Therapy in Adults
Griffiths, M. J. D., & Evans, T. W. (2005) · New England Journal of Medicine · doi:10.1056/nejmra051884 · Cited by 398
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease
Aslan, M., Ryan, T. M., Adler, B., Townes, T. M., Parks, D. A., Thompson, J. A., Tousson, A., Gladwin, M. T., Patel, R. P., Tarpey, M. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221292098 · Cited by 391
Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype
Topper, J. N., & Gimbrone Jr, M. A. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01372-0 · Cited by 390
Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor
Cowan, K. N., Heilbut, A., Humpl, T., Lam, C., Ito, S., & Rabinovitch, M. (2000) · Nature Medicine · doi:10.1038/76282 · Cited by 378
Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms
McQuillan, L. P., Leung, G. K., Marsden, P. A., Kostyk, S. K., & Kourembanas, S. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.267.5.h1921 · Cited by 375
McMurtry, M. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23203 · Cited by 368
Oxidative Stress in Severe Pulmonary Hypertension
Bowers, R., Cool, C., Murphy, R. C., Tuder, R. M., Hopken, M. W., Flores, S. C., & Voelkel, N. F. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200301-147oc · Cited by 366
Hansmann, G., Wagner, R. A., Schellong, S., de Jesus Perez, V. A., Urashima, T., Wang, L., Sheikh, A. Y., Suen, R. S., Stewart, D. J., & Rabinovitch, M. (2007) · Circulation · doi:10.1161/circulationaha.106.663120 · Cited by 366
Yang, X., Long, L., Southwood, M., Rudarakanchana, N., Upton, P. D., Jeffery, T. K., Atkinson, C., Chen, H., Trembath, R. C., & Morrell, N. W. (2005) · Circulation Research · doi:10.1161/01.res.0000166926.54293.68 · Cited by 364
Primary Pulmonary Hypertension in HIV Infection
Speich, R., Jenni, R., Opravil, M., Pfab, M., & Russi, E. W. (1991) · Chest · doi:10.1378/chest.100.5.1268 · Cited by 354
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension
Petkov, V., Mosgoeller, W., Ziesche, R., Raderer, M., Stiebellehner, L., Vonbank, K., Funk, G.-C., Hamilton, G., Novotny, C., Burian, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17500 · Cited by 352
Steele, P. M., Fuster, V, Cohen, M., Ritter, D. G., & McGoon, D. C. (1987) · Circulation · doi:10.1161/01.cir.76.5.1037 · Cited by 350
Chun, M., Liyanage, U. K., Lisanti, M. P., & Lodish, H. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11728 · Cited by 334
Oka, M., Homma, N., Taraseviciene-Stewart, L., Morris, K. G., Kraskauskas, D., Burns, N., Voelkel, N. F., & McMurtry, I. F. (2007) · Circulation Research · doi:10.1161/01.res.0000261658.12024.18 · Cited by 331
Teichert-Kuliszewska, K., Kutryk, M. J. B., Kuliszewski, M. A., Karoubi, G., Courtman, D. W., Zucco, L., Granton, J., & Stewart, D. J. (2006) · Circulation Research · doi:10.1161/01.res.0000200180.01710.e6 · Cited by 331
Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival
Castro, O., Hoque, M., & Brown, B. D. (2003) · Blood · doi:10.1182/blood-2002-03-0948 · Cited by 327
Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension
Jeffery, T. K., & Morrell, N. W. (2002) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2002.130041 · Cited by 317
Primary Pulmonary Hypertension and Cirrhosis: Are They Related? 1– 3
McDonnell, P. J., Toye, P. A., & Hutchins, G. M. (1983) · American Review of Respiratory Disease · doi:10.1164/arrd.1983.127.4.437 · Cited by 315
Cool, C. D., Stewart, J. S., Werahera, P., Miller, G. J., Williams, R. L., Voelkel, N. F., & Tuder, R. M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65137-1 · Cited by 309
Fagan, K. A., Fouty, B. W., Tyler, R. C., Morris, K. G., Hepler, L. K., Sato, K., LeCras, T. D., Abman, S. H., Weinberger, H. D., Huang, P. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3862 · Cited by 309
Fagan, K. A., Oka, M., Bauer, N. R., Gebb, S. A., Ivy, D. D., Morris, K. G., & McMurtry, I. F. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00090.2003 · Cited by 302
Cowan, K. N., Jones, P. L., & Rabinovitch, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci6539 · Cited by 302
Initial apoptosis is followed by increased proliferation of apoptosis‐resistant endothelial cells
Sakao, S., Taraseviciene‐Stewart, L., Lee, J. D., Wood, K., Cool, C. D., & Voelkel, N. F. (2005) · The FASEB Journal · doi:10.1096/fj.04-3261fje · Cited by 301
Attenuated K+ channel gene transcription in primary pulmonary hypertension
Yuan, X.-J., Wang, J., Juhaszova, M., Gaine, S. P., & Rubin, L. J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78495-6 · Cited by 298
Expression of Human Herpesvirus 8 in Primary Pulmonary Hypertension
Cool, C. D., Rai, P. R., Yeager, M. E., Hernandez-Saavedra, D., Serls, A. E., Bull, T. M., Geraci, M. W., Brown, K. K., Routes, J. M., Tuder, R. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035115 · Cited by 294
Chemokine RANTES in Severe Pulmonary Arterial Hypertension
DORFMÜLLER, P., ZARKA, V., DURAND-GASSELIN, I., MONTI, G., BALABANIAN, K., GARCIA, G., CAPRON, F., COULOMB-LHERMINÉ, A., MARFAING-KOKA, A., SIMONNEAU, G., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.4.2012112 · Cited by 288
Fukumoto, Y., Matoba, T., Ito, A., Tanaka, H., Kishi, T., Hayashidani, S., Abe, K., Takeshita, A., & Shimokawa, H. (2005) · Heart · doi:10.1136/hrt.2003.029470 · Cited by 286
Yeager, M. E., Halley, G. R., Golpon, H. A., Voelkel, N. F., & Tuder, R. M. (2001) · Circulation Research · doi:10.1161/01.res.88.1.e2 · Cited by 286
CX 3 C Chemokine Fractalkine in Pulmonary Arterial Hypertension
Balabanian, K., Foussat, A., Dorfmüller, P., Durand-Gasselin, I., Capel, F., Bouchet-Delbos, L., Portier, A., Marfaing-Koka, A., Krzysiek, R., Rimaniol, A.-C., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2106007 · Cited by 274
Rudarakanchana, N. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.13.1517 · Cited by 271
Castro, M., Krowka, M. J., Schroeder, D. R., Beck, K. C., Plevak, D. J., Rettke, S. R., Cortese, D. A., & Wiesner, R. H. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.6.543 · Cited by 266
Hsu, L. L., Champion, H. C., Campbell-Lee, S. A., Bivalacqua, T. J., Manci, E. A., Diwan, B. A., Schimel, D. M., Cochard, A. E., Wang, X., Schechter, A. N., et al. (2007) · Blood · doi:10.1182/blood-2006-08-039438 · Cited by 263
Cool, C. D., Kennedy, D., Voelkel, N. F., & Tuder, R. M. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90032-0 · Cited by 263
West, J., Fagan, K., Steudel, W., Fouty, B., Lane, K., Harral, J., Hoedt-Miller, M., Tada, Y., Ozimek, J., Tuder, R., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000126047.82846.20 · Cited by 263
Pozeg, Z. I., Michelakis, E. D., McMurtry, M. S., Thébaud, B., Wu, X.-C., Dyck, J. R. B., Hashimoto, K., Wang, S., Moudgil, R., Harry, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000062688.76508.b3 · Cited by 260
Chaouat, A. (2004) · Thorax · doi:10.1136/thx.2003.11890 · Cited by 250
Genetic basis of pulmonary arterial hypertension
Newman, J. H., Trembath, R. C., Morse, J. A., Grunig, E., Loyd, J. E., Adnot, S., Coccolo, F., Ventura, C., Phillips, J. A., Knowles, J. A., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.028 · Cited by 247
Eddahibi, S., Chaouat, A., Morrell, N., Fadel, E., Fuhrman, C., Bugnet, A.-S., Dartevelle, P., Housset, B., Hamon, M., Weitzenblum, E., et al. (2003) · Circulation · doi:10.1161/01.cir.0000091409.53101.e8 · Cited by 234
Prostanoid therapy for pulmonary arterial hypertension
Badesch, D. B., McLaughlin, V. V., Delcroix, M., Vizza, C. D., Olschewski, H., Sitbon, O., & Barst, R. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.036 · Cited by 228
The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats
Chunyu, Z., Junbao, D., Dingfang, B., Hui, Y., Xiuying, T., & Chaoshu, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00256-0 · Cited by 227
Aldred, M. A., Vijayakrishnan, J., James, V., Soubrier, F., Gomez-Sanchez, M. A., Martensson, G., Galie, N., Manes, A., Corris, P., Simonneau, G., et al. (2006) · Human Mutation · doi:10.1002/humu.9398 · Cited by 226
Keegan, A., Morecroft, I., Smillie, D., Hicks, M. N., & MacLean, M. R. (2001) · Circulation Research · doi:10.1161/hh2401.100426 · Cited by 225
Chand, N., & Altura, B. M. (1981) · Science · doi:10.1126/science.7268440 · Cited by 224
Weir, E. K., Reeve, H. L., Huang, J. M. C., Michelakis, E., Nelson, D. P., Hampl, V., & Archer, S. L. (1996) · Circulation · doi:10.1161/01.cir.94.9.2216 · Cited by 218
Yu, P. B., Beppu, H., Kawai, N., Li, E., & Bloch, K. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502825200 · Cited by 213
Increased Susceptibility to Pulmonary Hypertension in Heterozygous BMPR2-Mutant Mice
Song, Y., Jones, J. E., Beppu, H., Keaney, J. F., Loscalzo, J., & Zhang, Y.-Y. (2005) · Circulation · doi:10.1161/circulationaha.104.492488 · Cited by 211
Self-citationMacLean, M. R., Deuchar, G. A., Hicks, M. N., Morecroft, I., Shen, S., Sheward, J., Colston, J., Loughlin, L., Nilsen, M., Dempsie, Y., et al. (2004) · Circulation · doi:10.1161/01.cir.0000127375.56172.92 · Cited by 208
Christou, H., Morita, T., Hsieh, C.-M., Koike, H., Arkonac, B., Perrella, M. A., & Kourembanas, S. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1224 · Cited by 204
Serotonin Transporter Inhibitors Protect against Hypoxic Pulmonary Hypertension
Marcos, E., Adnot, S., Pham, M. H., Nosjean, A., Raffestin, B., Hamon, M., & Eddahibi, S. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1212oc · Cited by 204
Beppu, H., Ichinose, F., Kawai, N., Jones, R. C., Yu, P. B., Zapol, W. M., Miyazono, K., Li, E., & Bloch, K. D. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00239.2004 · Cited by 203
PATHOBIOLOGY OF PULMONARY HYPERTENSION
Herve, P., Humbert, M., Sitbon, O., Parent, F., Nunes, H., Legal, C., Garcia, G., & Simonneau, G. (2001) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70283-5 · Cited by 200
Jones, P. L., & Rabinovitch, M. (1996) · Circulation Research · doi:10.1161/01.res.79.6.1131 · Cited by 199
Guignabert, C., Izikki, M., Tu, L. I., Li, Z., Zadigue, P., Barlier-Mur, A.-M., Hanoun, N., Rodman, D., Hamon, M., Adnot, S., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000222546.45372.a0 · Cited by 196
Is Methamphetamine Use Associated With Idiopathic Pulmonary Arterial Hypertension?
Chin, K. M., Channick, R. N., & Rubin, L. J. (2006) · Chest · doi:10.1378/chest.130.6.1657 · Cited by 193
Mette, S. A., Palevsky, H. I., Pietra, G. G., Williams, T. M., Bruder, E., Prestipino, A. J., Patrick, A. M., & Wirth, J. A. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.5.1196 · Cited by 192
Simvastatin Attenuates Smooth Muscle Neointimal Proliferation and Pulmonary Hypertension in Rats
Nishimura, T., Faul, J. L., Berry, G. J., Vaszar, L. T., Qiu, D., Pearl, R. G., & Kao, P. N. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200203-268oc · Cited by 191
Liu, Y., Suzuki, Y. J., Day, R. M., & Fanburg, B. L. (2004) · Circulation Research · doi:10.1161/01.res.0000141428.53262.a4 · Cited by 189
Zaidi, S. H. E., You, X.-M., Ciura, S., Husain, M., & Rabinovitch, M. (2002) · Circulation · doi:10.1161/hc0402.102866 · Cited by 186
Leukotriene C4and D4in Neonates with Hypoxemia and Pulmonary Hypertension
Stenmark, K. R., James, S. L., Voelkel, N. F., Toews, W. H., Reeves, J. T., & Murphy, R. C. (1983) · New England Journal of Medicine · doi:10.1056/nejm198307143090204 · Cited by 183
Absence of T Cells Confers Increased Pulmonary Arterial Hypertension and Vascular Remodeling
Taraseviciene-Stewart, L., Nicolls, M. R., Kraskauskas, D., Scerbavicius, R., Burns, N., Cool, C., Wood, K., Parr, J. E., Boackle, S. A., & Voelkel, N. F. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200608-1189oc · Cited by 182
Sildenafil in the treatment of pulmonary hypertension
Barnett, C. F., & Machado, R. F. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.4.411 · Cited by 180
Moderate Pulmonary Arterial Hypertension in Male Mice Lacking the Vasoactive Intestinal Peptide Gene
Said, S. I., Hamidi, S. A., Dickman, K. G., Szema, A. M., Lyubsky, S., Lin, R. Z., Jiang, Y.-P., Chen, J. J., Waschek, J. A., & Kort, S. (2007) · Circulation · doi:10.1161/circulationaha.106.681718 · Cited by 177
Protective Role of Angiopoietin-1 in Experimental Pulmonary Hypertension
Zhao, Y. D., Campbell, A. I. M., Robb, M., Ng, D., & Stewart, D. J. (2003) · Circulation Research · doi:10.1161/01.res.0000070587.79937.f0 · Cited by 176
Unexplained Pulmonary Hypertension in Chronic Myeloproliferative Disorders
Dingli, D., Utz, J. P., Krowka, M. J., Oberg, A. L., & Tefferi, A. (2001) · Chest · doi:10.1378/chest.120.3.801 · Cited by 175
Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway
Sullivan, C. C., Du, L., Chu, D., Cho, A. J., Kido, M., Wolf, P. L., Jamieson, S. W., & Thistlethwaite, P. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1933740100 · Cited by 174
Cogolludo, A., Moreno, L., Lodi, F., Frazziano, G., Cobeño, L., Tamargo, J., & Perez-Vizcaino, F. (2006) · Circulation Research · doi:10.1161/01.res.0000216858.04599.e1 · Cited by 174
Hypoxic Activation of Adventitial Fibroblasts*
Stenmark, K. R., Gerasimovskaya, E., Nemenoff, R. A., & Das, M. (2002) · Chest · doi:10.1378/chest.122.6_suppl.326s · Cited by 172
Down-Regulation of Caveolin-1, a Candidate Tumor Suppressor Gene, in Sarcomas
Wiechen, K., Sers, C., Agoulnik, A., Arlt, K., Dietel, M., Schlag, P. M., & Schneider, U. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64031-x · Cited by 167
MOUDGIL, R., MICHELAKIS, E. D., & ARCHER, S. L. (2006) · Microcirculation · doi:10.1080/10739680600930222 · Cited by 167
Lung Biopsy Specimens in the Evaluation of Pulmonary Vascular Disease
Wagenvoort, C. A. (1980) · Chest · doi:10.1378/chest.77.5.614 · Cited by 166
Remillard, C. V., Tigno, D. D., Platoshyn, O., Burg, E. D., Brevnova, E. E., Conger, D., Nicholson, A., Rana, B. K., Channick, R. N., Rubin, L. J., et al. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00405.2006 · Cited by 165
Prevalence of pulmonary hypertension in limited and diffuse scleroderma
Battle, R. W., Davitt, M. A., Cooper, S. M., Buckley, L. M., Leib, E. S., Beglin, P. A., & Tischler, M. D. (1996) · Chest · doi:10.1378/chest.110.6.1515 · Cited by 158
Carbon monoxide reverses established pulmonary hypertension
Zuckerbraun, B. S., Chin, B. Y., Wegiel, B., Billiar, T. R., Czsimadia, E., Rao, J., Shimoda, L., Ifedigbo, E., Kanno, S., & Otterbein, L. E. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052267 · Cited by 158
Cardiopulmonary Assessment in Beta-Thalassemia Major
Grisaru, D., Rachmilewitz, E. A., Mosseri, M., Gotsman, M. S., Lafair, J. S., Okon, E., Goldfarb, A., & Hasin, Y. (1990) · CHEST Journal · doi:10.1378/chest.98.5.1138 · Cited by 155
Thromboxane A 2 -Induced Inhibition of Voltage-Gated K + Channels and Pulmonary Vasoconstriction
Cogolludo, A. L., Moreno, L., Boscá, L., Tamargo, J. L., & Pérez‐Vizcaíno, F. (2003) · Circulation Research · doi:10.1161/01.res.0000095245.97945.fe · Cited by 152
Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension
Stelzner, T. J., OʼBrien, R. F., Yanagisawa, M., et al. (1992) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1992.262.5.l614 · Cited by 150
Itoh, T., Nagaya, N., Ishibashi‐Ueda, H., Kyotani, S., Oya, H., Sakamaki, F., Kimura, H., & Nakanishi, N. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00821.x · Cited by 149
Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension
Reynolds, A. M., Xia, W., Holmes, M., Hodge, S. J., Danilov, S. M., Curiel, D. T., Morrell, N. W., & Reynolds, P. N. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00020.2006 · Cited by 147
Morty, R. E., Nejman-Faleńczyk, B., Kwapiszewska, G., Hecker, M., Zakrzewicz, A., Kouri, F. M., Peters, D. M., Dumitrascu, R., Seeger, W., Knaus, P. I., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.141200 · Cited by 145
Angiopoietin/Tie2 Pathway Influences Smooth Muscle Hyperplasia in Idiopathic Pulmonary Hypertension
Dewachter, L., Adnot, S., Fadel, É., Humbert, M. J. C., Maître, B., Barlier‐Mur, A., Simonneau, G., Hamon, M., Naeije, R., & Eddahibi, S. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-304oc · Cited by 140
Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease
Klings, E. S., & Farber, H. W. (2001) · Respiratory Research · doi:10.1186/rr70 · Cited by 132
Voelkel, N. F., Tuder, R. M., Wade, K., Höper, M., Lepley, R. A., Goulet, J. L., Koller, B. H., & Fitzpatrick, F. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118696 · Cited by 131
Kanmogne, G. D., Primeaux, C., & Grammas, P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.198 · Cited by 129
Lee, S. L., Wang, W. W., Lanzillo, J. J., & Fanburg, B. L. (1994) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1994.266.1.l46 · Cited by 129
Wright, L. A., Tuder, R. M., WANG, J., Cool, C. D., Lepley, R. A., & Voelkel, N. F. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704003 · Cited by 127
Launay, D., Mouthon, L., HACHULLA, E., Pagnoux, C., de Groote, P., Rémy‐Jardin, M., Matran, R., Lambert, M., Queyrel, V., Morell‐Dubois, S., et al. (2007) · PubMed · Cited by 121
Long-Term Inhibition of Rho-kinase Ameliorates Hypoxia-Induced Pulmonary Hypertension in Mice
Abe, K., Tawara, S., Oi, K., Hizume, T., Uwatoku, T., Fukumoto, Y., Kaibuchi, K., & Shimokawa, H. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000248244.64430.4a · Cited by 121
Primary Pulmonary Hypertension
Galiè, N., Manes, A., Uguccioni, L., Serafini, F., Rosa, M. D., Branzi, A., & Magnani, B. (1998) · CHEST Journal · doi:10.1378/chest.114.3_supplement.184s · Cited by 119
Hypoxic pulmonary vasoconstriction: role of voltage-gated potassium channels
Sweeney, M., & Yuan, J. X. ‐. (2000) · Respiratory Research · doi:10.1186/rr11 · Cited by 118
Loss of Caveolin and Heme Oxygenase Expression in Severe Pulmonary Hypertension
Achcar, R. D., Demura, Y., Rai, P. R., Tarasevičienė-Stewart, L., Kasper, M. E., Voelkel, N. F., & Cool, C. D. (2006) · CHEST Journal · doi:10.1378/chest.129.3.696 · Cited by 117
Jeffery, T. K., Upton, P. D., Trembath, R. C., & Morrell, N. W. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00242.2004 · Cited by 112
Bone Morphogenetic Protein Receptor Type II C-Terminus Interacts with c-Src
Wong, W. K. P., Knowles, J. A., & Morse, J. H. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0103oc · Cited by 104
Caveolae, Lipid Rafts, and Vascular Disease
Li, X., Everson, W. V., & Smart, E. J. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.04.001 · Cited by 104
Pulmonary Complications of Sickle Cell Anemia
Minter, K. R., & Gladwin, M. T. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.11.2104101 · Cited by 102
Elastase and the Pathobiology of Unexplained Pulmonary Hypertension
Rabinovitch, M. (1998) · CHEST Journal · doi:10.1378/chest.114.3_supplement.213s · Cited by 100
Increased plasma levels of adrenomedullin in patients with pulmonary hypertension
Kakishita, M., Nishikimi, T., Okano, Y., Satoh, T., Kyotani, S., Nagaya, N., Fukushima, K., Nakanishi, N., Takishita, S., Miyata, A., et al. (1999) · Clinical Science · doi:10.1042/cs0960033 · Cited by 99
Zhu, L., Wigle, D. A., Hinek, A., Kobayashi, J., Ye, C., Zuker, M., Dodo, H., Keeley, F. W., & Rabinovitch, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117432 · Cited by 99
Sata, M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000206123.94140.f3 · Cited by 98
Stimulant-Induced Pulmonary Toxicity
Albertson, T. E., Walby, W. F., & Derlet, R. W. (1995) · CHEST Journal · doi:10.1378/chest.108.4.1140 · Cited by 97
Zhu, P., Huang, L., Ge, X., Yan, F., Wu, R., & Ao, Q. (2006) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2006.00503.x · Cited by 96
Champion, H. C., Bivalacqua, T. J., Greenberg, S. S., Giles, T. D., Hyman, A. L., & Kadowitz, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182225899 · Cited by 95
Botney, M. D. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.2.9805075 · Cited by 93
Increased Fibulin-5 and Elastin in S100A4/Mts1 Mice With Pulmonary Hypertension
Merklinger, S. L., Wagner, R. A., Spiekerkoetter, E. F., Hinek, A., Knutsen, R. H., Kabir, M. G., Desai, K. H., Hacker, S., Wang, L., Cann, G. M., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000182425.49768.8a · Cited by 93
Rare diseases bullet 5: Primary pulmonary hypertension
Peacock, A. (1999) · Thorax · doi:10.1136/thx.54.12.1107 · Cited by 92
PATHOBIOLOGY OF PULMONARY HYPERTENSION
Rabinovitch, M. (2001) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70282-3 · Cited by 92
NO Contest: Nitrite Versus S -Nitroso-Hemoglobin
Gladwin, M. T., & Schechter, A. N. (2004) · Circulation Research · doi:10.1161/01.res.0000126697.64381.37 · Cited by 91
Sakao, S., Taraseviciene‐Stewart, L., Cool, C. D., Tada, Y., Kasahara, Y., Kurosu, K., Tanabe, N., Takiguchi, Y., Tatsumi, K., Kuriyama, T., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8432com · Cited by 86
Hypoxic pulmonary vasoconstriction
Dumas, J., Bardou, M., Goirand, F., & Dumas, M. (1999) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(99)00026-9 · Cited by 80
Perkett, E. A., Lyons, R. M., Moses, H. L., Brigham, K. L., & Meyrick, B. O. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114862 · Cited by 75
The 5‐HT transporter transactivates the PDGFβ receptor in pulmonary artery smooth muscle cells
Liu, Y., Li, M., Warburton, R. R., Hill, N. S., & Fanburg, B. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-8058com · Cited by 73
Lagna, G., Nguyen, P. H., Ni, W., & Hata, A. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00180.2006 · Cited by 70
Ortiz, L. A., Champion, H. C., Lasky, J. A., Gambelli, F., Gozal, E., Hoyle, G. W., Beasley, M. B., Hyman, A. L., Friedman, M. B., & Kadowitz, P. J. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00144.2001 · Cited by 68
Jiang, B. H., Tawara, S., Abe, K., Takaki, A., Fukumoto, Y., & Shimokawa, H. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31802df112 · Cited by 67
Pfander, D., Swoboda, B., & Cramer, T. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1894 · Cited by 67
Wanstall, J. C. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00440-6 · Cited by 67
Ihida‐Stansbury, K., McKean, D. M., Lane, K. B., Loyd, J. E., Wheeler, L. A., Morrell, N. W., & Jones, P. L. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00119.2006 · Cited by 63
Fantozzi, I., Platoshyn, O., Wong, A. H., Zhang, S., Remillard, C. V., Furtado, M. R., Petrauskene, O., & Yuan, J. X. ‐. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00191.2005 · Cited by 60
Li, M., Liu, Y., Dutt, P., Fanburg, B. L., & Toksoz, D. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00133.2007 · Cited by 60
Absence of Kaposi's Sarcoma–associated Herpesvirus in Patients with Pulmonary Arterial Hypertension
Henke‐Gendo, C., Mengel, M., Hoeper, M. M., Alkharsah, K. R., & Schulz, T. F. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-546oc · Cited by 57
Simvastatin enhances bone morphogenetic protein receptor type II expression
Hu, H., Sung, A. W., Zhao, G., Shi, L., Qiu, D., Nishimura, T., & Kao, P. N. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.187 · Cited by 54
Ramos, M. I., Lamé, M. W., Segall, H. J., & Wilson, D. W. (2005) · Vascular Pharmacology · doi:10.1016/j.vph.2005.09.007 · Cited by 54
Kawaguchi, Y., Tochimoto, A., Hara, M., Kawamoto, M., Sugiura, T., Katsumata, Y., Okada, J., Kondo, H., Okubo, M., & Kamatani, N. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1984 · Cited by 54
Effect of 5-lipoxygenase on the development of pulmonary hypertension in rats
Jones, J. E., Walker, J. L., Song, Y., et al. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00281.2003 · Cited by 54
Mitani, Y., Zaidi, S. H. E., Dufourcq, P., Thompson, K., & Rabinovitch, M. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.5.805 · Cited by 52
Yildiz, P., Oflaz, H., Çine, N., Erginel‐Ünaltuna, N., Erzengin, F., & Yilmaz, V. (2003) · Respiratory Medicine · doi:10.1016/j.rmed.2003.06.001 · Cited by 49
Gene transfer of a TIE2 receptor antagonist prevents pulmonary hypertension in rodents
Kido, M., Du, L., Sullivan, C. C., Deutsch, R., Jamieson, S. W., & Thistlethwaite, P. A. (2004) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2004.09.013 · Cited by 43
Dysfunction of Golgi tethers, SNAREs, and SNAPs in monocrotaline-induced pulmonary hypertension
Sehgal, P. B., Mukhopadhyay, S., Xu, F., et al. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00463.2006 · Cited by 43
Right ventricular cardiac dysfunction in beta-thalassemia major.
Koren, A., Garty, I., Antonelli, D., et al. (1987) · PubMed · Cited by 42
Effect of Dexfenfluramine Treatment in Rats Exposed to Acute and Chronic Hypoxia
Eddahibi, S., Raffestin, B., Launay, J., Sitbon, M., & Adnot, S. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9704095 · Cited by 41
Medhora, M. M., Bousamra, M., Zhu, D., Somberg, L. B., & Jacobs, E. R. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00292.2001 · Cited by 41
Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension
Langleben, D. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2006.11.002 · Cited by 40
Hypoxia Regulates Bone Morphogenetic Protein Signaling Through C-Terminal–Binding Protein 1
Wu, X., Chang, M. S., Mitsialis, S. A., & Kourembanas, S. (2006) · Circulation Research · doi:10.1161/01.res.0000237021.65103.24 · Cited by 40
The erbB/HER type 1 tyrosine kinase receptor family
Walker, R. A. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199807)185:3<313::aid-path93>3.0.co;2-8 · Cited by 38
Role of Angiopoietin-1 in Experimental and Human Pulmonary Arterial Hypertension
Kugathasan, L., Dutly, A., Zhao, Y. D., Deng, Y., Robb, M. J., Keshavjee, S. H., & Stewart, D. J. (2005) · CHEST Journal · doi:10.1378/chest.128.6_suppl.633s · Cited by 36
Lung disease in systemic sclerosis (scleroderma)
Bolster, M. B., & Silver, R. M. (1993) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(05)80269-9 · Cited by 35
Söderman, C., Eriksson, L. S., JUHLIN‐DANNFELT, A., Lundberg, J. M., Broman, L. M., & Holmgren, A. (1993) · Clinical Physiology · doi:10.1111/j.1475-097x.1993.tb00482.x · Cited by 34
Fantozzi, I., Huang, W. G., Zhang, J., Zhang, S., Platoshyn, O., Remillard, C. V., Thistlethwaite, P. A., & Yuan, J. X. ‐. (2005) · Experimental Lung Research · doi:10.1080/01902140500461026 · Cited by 32
Ghorishi, Z., Milstein, J. M., Poulain, F. R., Moon‐Grady, A. J., Tacy, T. A., Bennett, S. H., Fineman, J. R., & Eldridge, M. W. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01012.2006 · Cited by 23
No Role for Kaposi Sarcoma-Associated Herpesvirus in Pediatric Idiopathic Pulmonary Hypertension
Galambos, C., Montgomery, J. D., & Jenkins, F. J. (2005) · Pediatric Pulmonology · doi:10.1002/ppul.20349 · Cited by 22
Michelakis, E. D., McMurtry, M. S., Sonnenberg, B., & Archer, S. L. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8997-0_21 · Cited by 21
The Serotonin Pathway in Pulmonary Hypertension
Eddahibi, S., & Adnot, S. (2005) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-4.1.20 · Cited by 16
Eickelberg, O. (2003) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.10.017 · Cited by 13
Gender issues in pulmonary vascular disease
Robles, A. M., & Shure, D. (2004) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2004.01.007 · Cited by 6
Li, X.-H., Du, J., Ding, Y.-G., Jin, H., Bu, D.-F., Tang, X., & Tang, C.-S. (2006) · PubMed · Cited by 5
Cited by
Stenmark, K. R., Meyrick, B., Galie, N., Mooi, W. J., & McMurtry, I. F. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00217.2009 · Cited by 774
Pulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 664
Parikh, V. N., Jin, R. C., Rabello, S., Gulbahce, N., White, K., Hale, A., Cottrill, K. A., Shaik, R. S., Waxman, A. B., Zhang, Y.-Y., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.060269 · Cited by 265
Self-citationBarnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., et al. (2021) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 263
Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertension.
Lee, S.-J., Smith, A., Guo, L., Alastalo, T.-P., Li, M., Sawada, H., Liu, X., Chen, Z.-H., Ifedigbo, E., Jin, Y., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201005-0746oc · Cited by 217
Metadata
- Authors
- Chan, S. Y., & Loscalzo, J.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 44
- Issue
- 1
- Pages
- 14-30
- ISSN
- 0022-2828 (ISSN-L)
- OpenAlex
- W2006178366
- Cited by
- 265
- References
- 189
- FWCI
- 9.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.